Skip to content

EIA-F8 Enzymeimmunoassay Kit For Quant.

by Intl. Immunoassay Laboratories, Inc. 510(k)

Active United States

510(k) K821963

Overview

The Eia-f8 Enzymeimmunoassay Kit For Quant. is a test for qualitative and quantitative factor deficiency. It is classified as a hematology device used to measure specific factor levels.

This device is regulated under FDA 510(k) clearance K821963. It is manufactured by Intl. Immunoassay Laboratories, Inc. and is categorized under regulation number 864.7290.

AI-generated from registry data, 22 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK821963 Date27 Jul 1982ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
GGP
Device Class
Class II
Regulation
21 CFR Part 864.7290
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Other devices from Intl. Immunoassay Laboratories, Inc.

See all devices from Intl. Immunoassay Laboratories, Inc. →

Questions

  • What is the primary clinical use of the EIA-F8 Enzymeimmunoassay Kit?

    This device is designed for use in hematology to perform qualitative and quantitative measurements of specific factor deficiencies in patient samples.

  • What is the regulatory status of this test kit?

    The EIA-F8 Enzymeimmunoassay Kit is regulated under FDA 510(k) clearance number K821963, which confirms it has been found substantially equivalent to other legally marketed devices.

  • Under which medical specialty is this device categorized?

    This device is categorized under the Hematology medical specialty, specifically falling under regulation number 864.7290, which pertains to factor deficiency tests.